Results 21 to 30 of about 5,570,795 (235)

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

New England Journal of Medicine, 2017
BACKGROUND The comparative effectiveness of treatments for prostate cancer that is detected by prostate-specific antigen (PSA) testing remains uncertain.
F. C. Hamdy, J. Donovan, J. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, T. Peters, E. Turner, Richard M. Martin, J. Oxley, M. Robinson, J. Staffurth, E. Walsh, P. Bollina, J. Catto, A. Doble, A. Doherty, D. Gillatt, R. Kockelbergh, H. Kynaston, A. Paul, P. Powell, S. Prescott, D. Rosario, E. Rowe, D. E. Neal, D. E. Neal   +27 more
semanticscholar   +1 more source

CANCER OF THE PROSTATE [PDF]

Journal of the American Medical Association, 1914
The facts that the general subject of cancer presents even to-day one of our most serious and unsolved problems; that cancer of the prostate is a comparatively frequent and exceedingly distressful form of the disease; and the probability that by a more wide-spread application of the present available knowledge of this pathologic process the prevalent ...
openaire   +3 more sources

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Ca, 2018
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across ...
F. Bray, J. Ferlay, I. Soerjomataram, R. Siegel, Lindsey A. Torre, A. Jemal   +5 more
semanticscholar   +1 more source

Cancer Statistics, 2021

Ca, 2021
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence.
R. Siegel, K. D. Miller, Hannah E Fuchs, A. Jemal   +3 more
semanticscholar   +1 more source

Prostate cancer incidence in Golestan province, Iran (2004) [PDF]

, 2008
Prostate cancer is the most common cancer in men and therefore represents a major problem in public health.The aim of this study was to find and evaluate province-specific estimate of incidence in males by age groups for prostate cancer in Golestan ...
Kabir, M.J., Marjani, A.
core   +1 more source

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

Cancer Research, 2021
These findings reveal that induction of ferroptosis is a new therapeutic strategy for advanced prostate cancer as a monotherapy and in combination with second-generation antiandrogens.
A. Ghoochani, E. Hsu, Merve Aslan, M. Rice, Holly M. Nguyen, J. Brooks, E. Corey, R. Paulmurugan, Tanya Stoyanova   +8 more
semanticscholar   +1 more source

Components of cell-matrix linkage as potential new markers for prostate cancer [PDF]

, 2011
Prostate cancer is one of the most common tumor diseases worldwide. Often being non-aggressive, prostate tumors in these cases do not need immediate treatment.
Eble, Johannes Andreas, Navdaev, Alexey
core   +2 more sources

Abiraterone and increased survival in metastatic prostate cancer.

New England Journal of Medicine, 2011
BACKGROUND Biosynthesis of extragonadal androgen may contribute to the progression of castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of androgen biosynthesis, prolongs overall survival among patients with ...
J. D. de Bono, C. Logothetis, A. Molina, K. Fizazi, S. North, L. Chu, K. Chi, Robert J. Jones, O. Goodman, F. Saad, J. Staffurth, P. Mainwaring, S. Harland, T. Flaig, Thomas E. Hutson, T. Cheng, H. Patterson, J. Hainsworth, C. Ryan, C. Sternberg, S. Ellard, A. Fléchon, M. Saleh, M. Scholz, E. Efstathiou, A. Zivi, D. Bianchini, Y. Loriot, N. Chieffo, T. Kheoh, C. Haqq, H. Scher   +31 more
semanticscholar   +1 more source

The molecular basis for ethnic variation and histological subtype differences in prostate cancer. [PDF]

, 2013
Prostate cancer is a common malignancy among men in Western countries. Recently the morbidity and mortality of prostate cancer increase dramatically in several oriental countries including China.
Goldstein, Andrew S, Huang, Jiaoti, Zong, Yang   +2 more
core   +1 more source

Lifetime risk of prostate cancer overdiagnosis in Australia: Quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach [PDF]

, 2019
© 2019 Author(s). Objectives To quantify the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
Bell, Katy, Doust, Jenny, Glasziou, Paul, Hayen, Andrew, Pathirana, Thanya   +4 more
core   +3 more sources